Derangement of apoptosis in cancer

Lancet

Volumn 358, Issue 9279, 2001, Pages 345-346

  Eichhorst, Sören T ^a   Krammer, Peter H ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR; BCL2 INTERACTING DOMAIN PROTEIN; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; DEATH INDUCING SIGNALING COMPLEX; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; PROTEIN BCL 2; PROTEIN BCL X; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; DISEASE COURSE; HUMAN; LIGAND BINDING; MITOCHONDRION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL DETECTION;

EID: 0035806766     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05584-2     Document Type: Note

References (14)

1. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
2. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
3. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
4. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
5. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs
6. Mitochondrial control of cell death
7. Immune escape of tumors in vivo by expression of cellular FLICE- inhibitory protein
8. Molecular insights into the immunopathogenesis of follicular lymphoma
9. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia
10. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
11. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa- associated lymphoid tissue lymphomas
12. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
13. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand- expressing tumor cells - A mechanism of immune evasion?
14. Signaling through MHC class II molecules blocks CD95-induced apoptosis